ZLAB – zai lab limited - american depositary shares (US:NASDAQ)
Stock Stats
News
Zai Lab (ZLAB) had its price target lowered by JPMorgan Chase & Co. from $39.00 to $32.00. They now have an "overweight" rating on the stock.
Nationwide International Small Cap Fund Q4 2025 Commentary [Seeking Alpha]
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC) [Yahoo! Finance]
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)
Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight [Yahoo! Finance]
Form 4 Zai Lab Ltd For: Mar 17 Filed by: GAYNOR RICHARD
Form 4 Zai Lab Ltd For: Mar 04 Filed by: Edmondson Frazor Titus III
Form 4 Zai Lab Ltd For: Mar 04 Filed by: Smiley Joshua L
Form 4 Zai Lab Ltd For: Mar 04 Filed by: Amado Rafael
Form 4 Zai Lab Ltd For: Mar 04 Filed by: Chen Yajing
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.